BrightSpring Health Services Raises 2026 Revenue Outlook After Third-Quarter Sales Climb 26%

Aditi Sarkar

02 November 2026 10:39 PM AEDT

BrightSpring Health Services Raises 2026 Revenue Outlook After Third-Quarter Sales Climb 26%

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

BrightSpring raised its 2026 total Revenue guidance to between US$15.90 billion and US$16.13 billion on 30 October.
Third-quarter revenue rose 26% year on year to US$4.21 billion, led by the Pharmacy Solutions segment.
Adjusted EBITDA for Q3 2026 increased 42% to US$228 million, while adjusted EPS reached US$0.54 per share.
Leverage declined to 1.79x at 30 September 2026 from 2.15x at the end of June, with cash near US$718 million.

BrightSpring Health Services, Inc. (NASDAQ:BTSG) lifted its full-year revenue and Earnings outlook on 30 October 2026 after reporting a third quarter in which both of its operating segments grew revenue by more than a quarter. The healthcare services company also reported a sharp drop in leverage, supported by stronger operating cash flow.

Pharmacy and Provider Segments Drive Third-Quarter Growth

For Q3 2026, total revenue from continuing operations rose 26% to US$4.21 billion from US$3.33 billion a year earlier. Pharmacy Solutions revenue grew 26% to US$3.73 billion, while Provider Services revenue increased 31% to US$481 million.

Within pharmacy, prescriptions dispensed rose 2% to about 10.9 million, while revenue per script increased 24% and Gross Profit per script climbed 27%. In Provider Services, the home health care average daily census jumped 58% to 47,256, and rehab care persons served rose 9%. Effective 1 July 2026, the company moved its Rehab in Motion Business from Rehab Care into Home Health Care and recast prior periods.

Profitability and Balance Sheet Strengthen

Gross profit increased 32% to US$519 million in the quarter. On a GAAP basis, Net Income from continuing operations rose to US$100.8 million from US$37.5 million, and Diluted Earnings per Share from continuing operations reached US$0.46, compared with US$0.17. Adjusted EBITDA, a non-GAAP measure, grew 42% to US$228 million, and adjusted EPS rose to US$0.54 from US$0.30.

Operating cash flow nearly doubled to US$204.3 million in Q3 2026. Cash and equivalents stood at US$717.8 million at 30 September 2026, up from US$88.4 million at the end of 2025, after the company received about US$810.9 million from the sale of its Community Living business, completed on 30 March 2026. Over the nine months, it repaid US$332.3 million of long-term Debt and repurchased US$120.0 million of shares. Leverage fell to 1.79x from 2.15x at 30 June.

Higher 2026 Targets Set the Path Forward

BrightSpring now expects 2026 total revenue of US$15.90 billion to US$16.13 billion, up from the US$15.10 billion to US$15.43 billion range issued in July, representing growth of 23.2% to 24.9% excluding Community Living. Pharmacy segment revenue guidance moved to US$14.0 billion to US$14.2 billion from US$13.2 billion to US$13.5 billion, while the provider segment range was held at US$1.90 billion to US$1.93 billion.

Adjusted EBITDA guidance rose to US$850 million to US$860 million from US$820 million to US$845 million. The outlook excludes Community Living and any acquisitions not yet closed, and includes about US$35 million of expected 2026 adjusted EBITDA from the acquired Amedisys and LHC branches. Chief Executive Jon Rousseau said the company expects to deliver durable growth in 2027 and beyond.

FAQs

Q: What does BrightSpring Health Services do?

A: It operates two segments: Pharmacy Solutions, which dispensed about 10.9 million prescriptions in Q3 2026, and Provider Services, which includes home health care, rehab care and personal care.

Q: What is the updated 2026 adjusted EBITDA guidance?

A: BrightSpring expects adjusted EBITDA of US$850 million to US$860 million for 2026, up from US$820 million to US$845 million.

Q: When did BrightSpring sell its Community Living business?

A: The divestiture was completed on 30 March 2026, and the business is excluded from guidance.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.